Published online before print July 19, 2001, doi: 10.1161/hh1501.094265
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2001 American Heart Association, Inc.
Cellular Biology |
Phenotypic Modulation of Vascular Smooth Muscle Cells Induced by Unsaturated Lysophosphatidic Acids
From the Department of Neuroscience (K.H., M.T., W.N., K.Y., Y.O., K.S.), Osaka University Graduate School of Medicine, Osaka; Department of Cardiovascular Medicine (M.T., A.K.), Hokkaido University, Graduate School of Medicine, Sapporo; Department of Health Chemistry (J.A., H.A.), Graduate School of Pharmaceutical Sciences, The University of Tokyo; and Department of Neurosurgery (K.Y.), Iwate Medical University School of Medicine, Morioka, Japan.
Correspondence to Kenji Sobue, MD, PhD, Department of Neurosurgery, Iwate Medical University School of Medicine, 19-1 Uchimaru, Morioka 020-8505, Japan. E-mail sobue{at}nbiochem.med.osaka-u.ac.jp
Abstract— The phenotypic modulation of vascular smooth muscle cells (VSMCs) from the differentiated state to the dedifferentiated one is critically involved in the development and progression of atherosclerosis. Although many cytokines and growth factors have been reported as atherogenic factors, the critical pathogens for inducing atherosclerosis remain unknown, largely because proper examining systems of them have not been developed. We recently established primary culture systems for visceral SMCs and VSMCs in which both SMCs, when cultured on laminin with insulin-like growth factor-I, show a differentiated phenotype, as indicated by a spindle-like shape, ligand-induced contractility, and a high level of SMC differentiation marker gene expression. In this study, we searched for critical dedifferentiation factors for these SMCs using our culture system. We found that polar lipids extracted from human serum markedly induced VSMC dedifferentiation, and this activity was solely present in the lysophosphatidic acid (LPA) fraction. Among several LPA species detected in human serum lipids, unsaturated LPAs were identified as major contributors to the induction of VSMC dedifferentiation. Signaling and phenotype analyses revealed that unsaturated LPA–induced VSMC dedifferentiation is mediated through the coordinated activation of extracellular signal–regulated kinase and p38 mitogen–activated protein kinase. Thus, this report demonstrates the first finding that unsaturated LPAs, but not saturated LPAs, specifically induce VSMC phenotypic modulation, suggesting that these molecules could function as atherogenic factors.
Key Words: vascular smooth muscle cells • phenotypic modulation • lysophosphatidic acids • extracellular signal–regulated kinase • p38 mitogen-activated protein kinase
This article has been cited by other articles:
 |
|
 |
|
  A. L. Pyle, J. B. Atkinson, A. Pozzi, J. Reese, B. Eckes, J. M. Davidson, D. L. Crimmins, and P. P. Young Regulation of the Atheroma-Enriched Protein, SPRR3, in Vascular Smooth Muscle Cells through Cyclic Strain is Dependent on Integrin {alpha}1{beta}1/Collagen Interaction Am. J. Pathol., November 1, 2008; 173(5): 1577 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-J. Lee, T.-H. Chan, T.-C. Chen, B.-K. Liao, P.-P. Hwang, and H. Lee LPA1 is essential for lymphatic vessel development in zebrafish FASEB J, October 1, 2008; 22(10): 3706 - 3715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Panchatcharam, S. Miriyala, F. Yang, M. Rojas, C. End, C. Vallant, A. Dong, K. Lynch, J. Chun, A. J. Morris, et al. Lysophosphatidic Acid Receptors 1 and 2 Play Roles in Regulation of Vascular Injury Responses but Not Blood Pressure Circ. Res., September 12, 2008; 103(6): 662 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kim, L. Zhang, K. Peppel, J.-H. Wu, D. A. Zidar, L. Brian, S. M. DeWire, S. T. Exum, R. J. Lefkowitz, and N. J. Freedman {beta}-Arrestins Regulate Atherosclerosis and Neointimal Hyperplasia by Controlling Smooth Muscle Cell Proliferation and Migration Circ. Res., July 3, 2008; 103(1): 70 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Jeon, H. J. Moon, M. J. Lee, H. Y. Song, Y. M. Kim, M. Cho, D.-S. Suh, M.-S. Yoon, C. L. Chang, J. S. Jung, et al. Cancer-Derived Lysophosphatidic Acid Stimulates Differentiation of Human Mesenchymal Stem Cells to Myofibroblast-Like Cells Stem Cells, March 1, 2008; 26(3): 789 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yoshioka, N. Sugimoto, N. Takuwa, and Y. Takuwa Essential Role for Class II Phosphoinositide 3-kinase {alpha}-Isoform in Ca2+-Induced, Rho- and Rho Kinase-Dependent Regulation of Myosin Phosphatase and Contraction in Isolated Vascular Smooth Muscle Cells Mol. Pharmacol., March 1, 2007; 71(3): 912 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hayashi, S. Nakamura, W. Nishida, and K. Sobue Bone Morphogenetic Protein-Induced Msx1 and Msx2 Inhibit Myocardin-Dependent Smooth Muscle Gene Transcription Mol. Cell. Biol., December 15, 2006; 26(24): 9456 - 9470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kotarsky, A. Boketoft, J. Bristulf, N. E. Nilsson, A. Norberg, S. Hansson, C. Owman, R. Sillard, L. M. F. Leeb-Lundberg, and B. Olde Lysophosphatidic Acid Binds to and Activates GPR92, a G Protein-Coupled Receptor Highly Expressed in Gastrointestinal Lymphocytes J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 619 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kaplan-Albuquerque, V. Van Putten, M. C. Weiser-Evans, and R. A. Nemenoff Depletion of Serum Response Factor by RNA Interference Mimics the Mitogenic Effects of Platelet Derived Growth Factor-BB in Vascular Smooth Muscle Cells Circ. Res., September 2, 2005; 97(5): 427 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hayashi, K. Shibata, T. Morita, K. Iwasaki, M. Watanabe, and K. Sobue Insulin Receptor Substrate-1/SHP-2 Interaction, a Phenotype-dependent Switching Machinery of Insulin-like Growth Factor-I Signaling in Vascular Smooth Muscle Cells J. Biol. Chem., September 24, 2004; 279(39): 40807 - 40818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zhang, D. L. Baker, S. Yasuda, N. Makarova, L. Balazs, L. R. Johnson, G. K. Marathe, T. M. McIntyre, Y. Xu, G. D. Prestwich, et al. Lysophosphatidic Acid Induces Neointima Formation Through PPAR{gamma} Activation J. Exp. Med., March 15, 2004; 199(6): 763 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Martin, E. M. Rzucidlo, B. L. Merenick, D. C. Fingar, D. J. Brown, R. J. Wagner, and R. J. Powell The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation Am J Physiol Cell Physiol, March 1, 2004; 286(3): C507 - C517. [Abstract] [Full Text]
|
|
|
|
|
|
T. Hiramatsu, H. Sonoda, Y. Takanezawa, R. Morikawa, M. Ishida, K. Kasahara, Y. Sanai, R. Taguchi, J. Aoki, and H. Arai Biochemical and Molecular Characterization of Two Phosphatidic Acid-selective Phospholipase A1s, mPA-PLA1{alpha} and mPA-PLA1{beta} J. Biol. Chem., December 5, 2003; 278(49): 49438 - 49447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Takahashi, K.'i. Hayashi, K. Yoshida, Y. Ohkawa, T. Komurasaki, A. Kitabatake, A. Ogawa, W. Nishida, M. Yano, M. Monden, et al. Epiregulin as a Major Autocrine/Paracrine Factor Released From ERK- and p38MAPK-Activated Vascular Smooth Muscle Cells Circulation, November 18, 2003; 108(20): 2524 - 2529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yoshida, W. Nishida, K.'i. Hayashi, Y. Ohkawa, A. Ogawa, J. Aoki, H. Arai, and K. Sobue Vascular Remodeling Induced by Naturally Occurring Unsaturated Lysophosphatidic Acid In Vivo Circulation, October 7, 2003; 108(14): 1746 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-Z. Cui, G. Zhao, A. L. Winokur, E. Laag, J. R. Bydash, M. S. Penn, G. M. Chisolm, and X. Xu Lysophosphatidic Acid Induction of Tissue Factor Expression in Aortic Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): 224 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Aoki, A. Taira, Y. Takanezawa, Y. Kishi, K. Hama, T. Kishimoto, K. Mizuno, K. Saku, R. Taguchi, and H. Arai Serum Lysophosphatidic Acid Is Produced through Diverse Phospholipase Pathways J. Biol. Chem., December 6, 2002; 277(50): 48737 - 48744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tokumura, E. Majima, Y. Kariya, K. Tominaga, K. Kogure, K. Yasuda, and K. Fukuzawa Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase J. Biol. Chem., October 11, 2002; 277(42): 39436 - 39442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sano, D. Baker, T. Virag, A. Wada, Y. Yatomi, T. Kobayashi, Y. Igarashi, and G. Tigyi Multiple Mechanisms Linked to Platelet Activation Result in Lysophosphatidic Acid and Sphingosine 1-Phosphate Generation in Blood J. Biol. Chem., June 7, 2002; 277(24): 21197 - 21206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tokumura, Y. Kanaya, M. Kitahara, M. Miyake, Y. Yoshioka, and K. Fukuzawa Increased formation of lysophosphatidic acids by lysophospholipase D in serum of hypercholesterolemic rabbits J. Lipid Res., February 1, 2002; 43(2): 307 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tigyi Selective Ligands for Lysophosphatidic Acid Receptor Subtypes: Gaining Control over the Endothelial Differentiation Gene Family Mol. Pharmacol., December 1, 2001; 60(6): 1161 - 1164. [Full Text] [PDF]
|
|